Go Pro
LON:OBI

Ondine Biomedical (OBI) Share Price, News & Analysis

Ondine Biomedical logo
C$13.75 +0.25 (+1.85%)
As of 08/10/2026 05:20 PM Eastern

About Ondine Biomedical Stock (LON:OBI)

Advanced

Key Stats

Today's Range
C$13.68
C$14.00
50-Day Range
C$12.55
C$15.40
52-Week Range
C$7.50
C$18.50
Volume
134,280 shs
Average Volume
428,195 shs
Market Capitalization
C$7.14 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.

Receive OBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OBI Stock News Headlines

Ondine Biomedical Inc.
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
Ondine Biomedical Inc Common Share OBI
See More Headlines

OBI Stock Analysis - Frequently Asked Questions

Ondine Biomedical's stock was trading at C$8.75 on January 1st, 2026. Since then, OBI shares have increased by 57.1% and is now trading at C$13.75.

Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ondine Biomedical investors own include AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX), Abacus Health Products (ABAHF) and Aurora Cannabis (ACB).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
LON:OBI
Previous Symbol
LON:OBI
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($6.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$424.66 thousand
Net Margins
-1,117.06%
Pretax Margin
N/A
Return on Equity
-1,411.54%
Return on Assets
-159.71%

Debt

Debt-to-Equity Ratio
11.85
Current Ratio
1.23
Quick Ratio
8.26

Sales & Book Value

Annual Sales
C$2.65 million
Price / Sales
2,699.86
Cash Flow
C$6.91 per share
Price / Cash Flow
1.99
Book Value
C$0.01 per share
Price / Book
1,592.42

Miscellaneous

Outstanding Shares
519,551,000
Free Float
N/A
Market Cap
C$7.14 billion
Optionable
Not Optionable
Beta
0.32
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (LON:OBI) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners